Literature DB >> 9551779

Synergistic effect of status epilepticus and ischemic brain injury on mortality.

E J Waterhouse1, J K Vaughan, T Y Barnes, J G Boggs, A R Towne, L Kopec-Garnett, R J DeLorenzo.   

Abstract

Ischemic brain injury (stroke) is a major cause of status epilepticus (SE). In our database of 529 adult SE cases, acute or remote cerebrovascular accidents (CVA) were a primary cause of SE for 41% of the patients overall and for 61% of the elderly patients. SE in the setting of acute CVA has a very high mortality, approaching 35%. The degree to which mortality can be attributed to the severity of the underlying CVA etiology vs. the effect of SE has not been evaluated. To address this issue, we prospectively studied patients with SE and acute CVA and compared them to control populations with acute CVA alone or with SE and remote CVA. The groups did not significantly differ with regard to age, sex, or radiographic lesion size. Mortality was unrelated to lesion size in the CVA and SE group. Overall, acute CVA and SE patients had an almost three-fold increase in mortality compared to the CVA group and an eight-fold increase compared to the SE and the non acute (remote) CVA group. Logistic regression analysis demonstrated a statistically significant synergistic effect of SE and CVA on mortality. This is the first study to document that the high mortality of SE and acute CVA is not solely due to the severity of the underlying CVA etiology, but due to the synergistic effect of combined injuries from SE and cerebral vascular ischemia.

Entities:  

Mesh:

Year:  1998        PMID: 9551779     DOI: 10.1016/s0920-1211(97)00071-5

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  24 in total

1.  Quantitative EEG analysis for automated detection of nonconvulsive seizures in intensive care units.

Authors:  J Chris Sackellares; Deng-Shan Shiau; Jonathon J Halford; Suzette M LaRoche; Kevin M Kelly
Journal:  Epilepsy Behav       Date:  2011-12       Impact factor: 2.937

2.  Mortality Associated with Status Epilepticus.

Authors:  Jane G. Boggs
Journal:  Epilepsy Curr       Date:  2004-01       Impact factor: 7.500

Review 3.  Outcome of convulsive status epilepticus: a review.

Authors:  Claire L Novorol; Richard F M Chin; Rod C Scott
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

4.  Absence of early epileptiform abnormalities predicts lack of seizures on continuous EEG.

Authors:  Mouhsin M Shafi; M Brandon Westover; Andrew J Cole; Ronan D Kilbride; Daniel B Hoch; Sydney S Cash
Journal:  Neurology       Date:  2012-10-10       Impact factor: 9.910

Review 5.  Treating epilepsy in the elderly: safety considerations.

Authors:  S Arroyo; G Kramer
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

6.  Modeling early-onset post-ischemic seizures in aging mice.

Authors:  Chiping Wu; Justin Wang; Jessie Peng; Nisarg Patel; Yayi Huang; Xiaoxing Gao; Salman Aljarallah; James H Eubanks; Robert McDonald; Liang Zhang
Journal:  Exp Neurol       Date:  2015-05-02       Impact factor: 5.330

7.  Inter-rater agreement on identification of electrographic seizures and periodic discharges in ICU EEG recordings.

Authors:  J J Halford; D Shiau; J A Desrochers; B J Kolls; B C Dean; C G Waters; N J Azar; K F Haas; E Kutluay; G U Martz; S R Sinha; R T Kern; K M Kelly; J C Sackellares; S M LaRoche
Journal:  Clin Neurophysiol       Date:  2014-11-20       Impact factor: 3.708

8.  Calculating the risk benefit equation for aggressive treatment of non-convulsive status epilepticus.

Authors:  Matthew Ferguson; Matt T Bianchi; Raoul Sutter; Eric S Rosenthal; Sydney S Cash; Peter W Kaplan; M Brandon Westover
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

Review 9.  Nonconvulsive status epilepticus in adults - insights into the invisible.

Authors:  Raoul Sutter; Saskia Semmlack; Peter W Kaplan
Journal:  Nat Rev Neurol       Date:  2016-04-11       Impact factor: 42.937

Review 10.  Poststroke epilepsy: epidemiology, pathophysiology and management.

Authors:  José M Ferro; Francisco Pinto
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.